Circulating tumor DNA as a marker of residual tumor in colon cancer

M Yu Fedyanin,U A Boyarskikh,E V Moroz,A V Polyakov,T S Ayrapetyan,V A Aliev,Kh Kh.-M Elsnukaeva,A A Kechin,S А Tjulandin,V A Uymanov,M L Filipenko

doi:10.17650/2220-3478-2018-8-3-11-16

Abstract

Colon cancer is the 3rdmost common malignant neoplasm and the 4thleading cause of mortality from them. The majority of patients are diagnosed at stages II–IV, which indicates the need for markers that can predict disease progression, especially after surgical treatment. Recently, there has been a growing interest in exploring circulating tumor DNA as a marker of residual tumor in colon cancer. In 2018, the N.N. Blokhin National Medical Research Center of Oncology together with the Institute of Chemical Biology and Fundamental Medicine under the coordination of the Center for Strategic Planning and Management of Biomedical Health Risks initiated a research project entitled “Development of an assay for the diagnosis of various malignant tumors and treatment efficacy monitoring based on the analysis of circulating tumor DNA from patient blood”. This article provides a theoretical background for the project and a report on its progress made so far.

Highlights

На рак толстой кишки приходится 3‐е место по заболеваемости злокачественными новообразованиями в мире и 4‐е место по смертности от них
The majority of patients are diagnosed at stages II–IV, which indicates the need for markers that can predict disease progression, especially after surgical treatment
Blokhin National Medical Research Center of Oncology together with the Institute of Chemical Biology and Fundamental Medicine under the coordination of the Center for Strategic Planning and Management of Biomedical Health Risks initiated a research project entitled “Development of an assay for the diagnosis of various malignant tumors and treatment efficacy monitoring based on the analysis of circulating tumor DNA from patient blood”

Summary

Introduction

На рак толстой кишки приходится 3‐е место по заболеваемости злокачественными новообразованиями в мире и 4‐е место по смертности от них. For citation: Fedyanin M.Yu., Elsnukaeva Kh.Kh.-M., Aliev V.A. et al Circulating tumor DNA as a marker of residual tumor in colon cancer.

Results

Conclusion